Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)
Go back to Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.62 -0.44 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.06 | 52 Week High | $77.12 | |||
| Open | $63.09 | 52 Week Low | $49.03 | |||
| Day High | $63.40 | P/E | 40.66 | |||
| Day Low | $62.62 | EPS | $1.54 | |||
| Volume | 6,838,963 | |||||
